Algert Global Portfolio holdings
Algert Global is a systematic equity manager that uses data science and machine learning to rank stocks against each other. Peter Algert, a former head of research for stock selection strategies at Barclays Global Investors, co-founded the firm in 2002 and is its chief executive and co-chief investment officer. The firm, called Algert Coldiron Investors until 2014, runs long-only, extension and market neutral strategies: the extension strategies take both long and short positions, and the market neutral strategy aims for returns that do not depend on the direction of global markets. Its clients include pension funds, insurance companies and sovereign wealth funds, and its employees own it.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EnerSys
ENS
|
+$23.6M |
| 2 |
SM Energy
SM
|
+$20.1M |
| 3 |
Kemper
KMPR
|
+$20.1M |
| 4 |
Freshworks
FRSH
|
+$19.9M |
| 5 |
Sabra Healthcare REIT
SBRA
|
+$19.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comfort Systems
FIX
|
+$37.2M |
| 2 |
Credo Technology Group
CRDO
|
+$23.6M |
| 3 |
Insmed
INSM
|
+$20.8M |
| 4 |
Group 1 Automotive
GPI
|
+$20.6M |
| 5 |
Workiva
WK
|
+$18.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.19% |
| 2 | Technology | 16.08% |
| 3 | Healthcare | 14.89% |
| 4 | Financials | 14.43% |
| 5 | Consumer Discretionary | 12.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.8T
| $46M | 0.72% |
169,217
+19,786
| +13% | +$5.31M |
2023 Q4
8 quarters
|
|
2
NVIDIA
NVDA
$5.01T
| $40.8M | 0.64% |
219,006
+29,735
| +16% | +$5.53M |
2024 Q3
5 quarters
|
|
3
Microsoft
MSFT
$3.82T
| $40.5M | 0.63% |
83,689
+12,425
| +17% | +$6.23M |
2024 Q3
5 quarters
|
|
4
TechnipFMC
FTI
$26.5B
| $40.5M | 0.63% |
907,826
+6,477
| +0.7% | +$274K |
2021 Q3
17 quarters
|
|
5
Nextpower Inc. Common Stock
NXT
$14.8B
| $38.6M | 0.6% |
443,454
-108,171
| -20% | -$9.8M |
2023 Q4
8 quarters
|
|
6
Primoris Services
PRIM
$4.18B
| $35.2M | 0.55% |
283,748
+27,174
| +11% | +$3.55M |
2022 Q3
13 quarters
|
|
7
Mueller Industries
MLI
$12.1B
| $35.2M | 0.55% |
612,834
-156,598
| -20% | -$8.42M |
2021 Q2
18 quarters
|
|
8
Watts Water Technologies
WTS
$12B
| $35.2M | 0.55% |
127,361
+34,463
| +37% | +$9.5M |
2021 Q3
17 quarters
|
|
|
9
EnerSys
ENS
$6.01B
| $33.8M | 0.53% |
230,514
+176,514
| +327% | +$23.6M |
2025 Q1
3 quarters
|
|
10
Balchem Corp
BCPC
$5.58B
| $33.2M | 0.52% |
216,324
+21,921
| +11% | +$3.35M |
2023 Q4
8 quarters
|
|
11
EXL Service
EXLS
$6.39B
| $32.8M | 0.51% |
772,114
+411,339
| +114% | +$16.8M |
2022 Q4
12 quarters
|
|
12
Matsons
MATX
$6.73B
| $32.5M | 0.51% |
262,967
+93,125
| +55% | +$10M |
2022 Q1
15 quarters
|
|
13
Sandisk
SNDK
$163B
| $31.8M | 0.5% |
133,899
-11,643
| -8% | -$2.33M |
2025 Q2
2 quarters
|
|
14
Portland General Electric
POR
$5.39B
| $30.9M | 0.48% |
644,307
-42,810
| -6% | -$2.02M |
2021 Q3
17 quarters
|
|
15
DELISTED
Synovus
SNV
| $30.2M | 0.47% |
603,858
+158,680
| +36% | +$7.63M |
2021 Q3
17 quarters
|
|
16
Axos Financial
AX
$5.4B
| $29.9M | 0.47% |
346,800
+17,320
| +5% | +$1.43M |
2022 Q1
15 quarters
|
|
17
Atmus Filtration Technologies
ATMU
$3.97B
| $29.6M | 0.46% |
569,937
+101,873
| +22% | +$4.93M |
2024 Q2
6 quarters
|
|
18
Jackson Financial
JXN
$9.47B
| $29.5M | 0.46% |
276,794
+35,290
| +15% | +$3.51M |
2023 Q4
8 quarters
|
|
19
BWX Technologies
BWXT
$12.3B
| $29M | 0.45% |
168,070
+60,170
| +56% | +$11.3M |
2021 Q3
17 quarters
|
|
20
American Healthcare REIT
AHR
$12B
| $29M | 0.45% |
616,644
+209,747
| +52% | +$9.7M |
2024 Q4
4 quarters
|
|
|
21
Freshworks
FRSH
$3.71B
| $28M | 0.44% |
2,285,290
+1,687,764
| +282% | +$19.9M |
2024 Q2
6 quarters
|
|
22
DELISTED
Taylor Morrison
TMHC
| $27.5M | 0.43% |
467,809
+288,663
| +161% | +$17.6M |
2021 Q3
17 quarters
|
|
23
MasTec
MTZ
$15.9B
| $27.4M | 0.43% |
126,235
+6,931
| +6% | +$1.45M |
2023 Q4
8 quarters
|
|
24
Axsome Therapeutics
AXSM
$7.38B
| $27.3M | 0.43% |
149,392
+105,242
| +238% | +$14.7M |
2025 Q1
3 quarters
|
|
25
BridgeBio Pharma
BBIO
$14.9B
| $26.1M | 0.41% |
341,048
+226,185
| +197% | +$14.8M |
2025 Q2
2 quarters
|
|
Similar funds
Algert Global's Q4 2025 Portfolio in Review
As of Q4 2025, Algert Global held 1,357 positions worth $6.41B, up 7.3% from $5.98B the previous quarter. Its ten largest holdings account for 5.9% of the portfolio.
Algert Global deployed $262M of net new capital in Q4 2025, opening 244 new positions and adding to 460 existing holdings. Its largest new stake was Roivant Sciences: 706,554 shares worth $15.3M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Comfort Systems, an estimated $37.2M trimmed.
- Algert Global's largest Q4 2025 buy was Roivant Sciences: 706,554 shares worth $15.3M.
- Algert Global added most to EnerSys in Q4 2025, an estimated $23.6M increase.
- Algert Global's biggest Q4 2025 reduction was Comfort Systems, cutting an estimated $37.2M.
- Algert Global fully exited Insmed in Q4 2025, selling an estimated $20.8M.
- Algert Global's ten largest holdings make up 5.9% of its $6.41B portfolio in Q4 2025.
- Algert Global opened 244 new positions and closed 237 in Q4 2025.
- Algert Global's portfolio value rose 7.3% quarter-over-quarter to $6.41B.
Based on Algert Global's 13F filing for Q4 2025, filed 17 Feb 2026.